Lee & Man Chemical Company Limited (HKG:0746)
Hong Kong · Delayed Price · Currency is HKD 4.530
+0.020 (0.44%)
Aug 24, 2026, 3:57 PM HKT
HKG:0746 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,991 | 3,755 | 3,951 | 4,051 | 5,867 | 5,186 | |
Revenue Growth | 2.52% | -4.96% | -2.46% | -30.96% | 13.13% | 67.31% |
Cost of Revenue | 2,623 | 2,460 | 2,787 | 2,988 | 3,743 | 2,847 |
Gross Profit | 1,368 | 1,295 | 1,164 | 1,062 | 2,124 | 2,339 |
Selling, General & Admin | 477.77 | 456.11 | 477.74 | 468.13 | 531.3 | 532.48 |
Research & Development | 162.29 | 169.03 | 135.8 | 120.75 | 204.01 | 230.89 |
Operating Expenses | 640.06 | 625.14 | 613.54 | 588.88 | 735.3 | 763.37 |
Operating Income | 727.59 | 669.65 | 550.51 | 473.29 | 1,388 | 1,576 |
Interest Expense | -20.74 | -17.3 | -21.9 | -39.28 | -38.66 | -47.62 |
Interest & Investment Income | 4.43 | 6.41 | 4.59 | 4.54 | 5.9 | 4.79 |
Earnings From Equity Investments | 4.09 | 5.26 | 3.69 | 0.54 | 0.31 | -1.25 |
Currency Exchange Gain (Loss) | -31.63 | -11.94 | 2.35 | -6.98 | -21.01 | 23.25 |
Other Non Operating Income (Expenses) | 61.17 | 61.08 | 59.4 | 73.3 | 60.95 | 61.15 |
EBT Excluding Unusual Items | 744.9 | 713.16 | 598.64 | 505.41 | 1,396 | 1,616 |
Gain (Loss) on Sale of Investments | - | - | - | - | 5.17 | -3.09 |
Gain (Loss) on Sale of Assets | -1.25 | -1.36 | -2.44 | -2.67 | -2.79 | -1.7 |
Asset Writedown | -15.82 | -5.5 | - | -8.84 | - | - |
Pretax Income | 727.83 | 706.31 | 596.2 | 493.9 | 1,398 | 1,611 |
Income Tax Expense | 146.71 | 148.05 | 113.91 | 93.23 | 241.34 | 323.07 |
Earnings From Continuing Operations | 581.12 | 558.26 | 482.28 | 400.67 | 1,157 | 1,288 |
Net Income | 581.12 | 558.26 | 482.28 | 400.67 | 1,157 | 1,288 |
Net Income to Common | 581.12 | 558.26 | 482.28 | 400.67 | 1,157 | 1,288 |
Net Income Growth | 2.16% | 15.75% | 20.37% | -65.36% | -10.19% | 156.26% |
Shares Outstanding (Basic) | 825 | 825 | 825 | 825 | 825 | 825 |
Shares Outstanding (Diluted) | 849 | 838 | 825 | 838 | 861 | 854 |
Shares Change | 2.76% | 1.58% | -1.58% | -2.62% | 0.85% | 3.47% |
EPS (Basic) | 0.70 | 0.68 | 0.58 | 0.49 | 1.40 | 1.56 |
EPS (Diluted) | 0.68 | 0.67 | 0.58 | 0.48 | 1.34 | 1.51 |
EPS Growth | -0.66% | 13.93% | 22.30% | -64.44% | -10.93% | 147.78% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 238.78 | 563.53 | 291.28 | 208.35 | 988.84 | 806.91 |
Free Cash Flow Per Share | 0.28 | 0.67 | 0.35 | 0.25 | 1.15 | 0.94 |
Dividend Per Share | 0.350 | 0.335 | 0.290 | 0.190 | 0.550 | 0.580 |
Dividend Growth | 1.45% | 15.52% | 52.63% | -65.45% | -5.17% | 141.67% |
Gross Margin | 34.27% | 34.48% | 29.46% | 26.22% | 36.19% | 45.10% |
Operating Margin | 18.23% | 17.84% | 13.93% | 11.68% | 23.66% | 30.38% |
Profit Margin | 14.56% | 14.87% | 12.21% | 9.89% | 19.72% | 24.84% |
Free Cash Flow Margin | 5.98% | 15.01% | 7.37% | 5.14% | 16.85% | 15.56% |
EBITDA | 857.39 | 753.48 | 623.64 | 531.94 | 1,460 | 1,628 |
EBITDA Margin | 21.48% | 20.07% | 15.78% | 13.13% | 24.89% | 31.38% |
D&A For EBITDA | 129.8 | 83.83 | 73.13 | 58.66 | 71.98 | 52.02 |
EBIT | 727.59 | 669.65 | 550.51 | 473.29 | 1,388 | 1,576 |
EBIT Margin | 18.23% | 17.84% | 13.93% | 11.68% | 23.66% | 30.38% |
Effective Tax Rate | 20.16% | 20.96% | 19.11% | 18.88% | 17.26% | 20.05% |
Revenue as Reported | - | - | - | 4,051 | 5,867 | 5,186 |